Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Slovenia New bill would regulate cannabis for medical and scientific purposes ...
  • Austria Cannabis association says Tobacco Monopoly Act shouldn’t apply to hemp flowers ...
  • Europe European Council approves omnibus package on sustainability ...
  • United Kingdom FSA response to CTA brings progress and clarification to CBD regulation ...
  • Arkansas - United States Governor vetoes medical cannabis delivery bill ...
  • Kazakhstan Allowing cultivation of low-THC industrial hemp variety being discussed ...
  • Italy TAR rejects appeal against decree on CBD classification ...
  • Minnesota - United States OCM cannabis rules published, licence issuing can begin ...
  • United Kingdom MHRA makes statement about CBD-containing products ...
  • Israel Custom duty to be placed on Canadian medical cannabis imports ...
  • Italy Security Bill text published in Official Gazette ...
  • Kansas - United States Governor calls on legislature to legalise medical cannabis ...
News analysis

SAFE Act and US medical cannabis research bill look dead in the water

Written by || 27th February 2020 || News analysis | Regulation and legislation | GeographiesNorth America United States

Two bills in the US House of Representatives, relating to banking and medical cannabis research, appear to be dead, with not enough time to pass the measures in 2020 despite wide support
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.